Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration

Author:

Anderson Kenneth C.,Auclair Daniel,Adam Stacey J.ORCID,Agarwal Amit,Anderson MelissaORCID,Avet-Loiseau Hervé,Bustoros MarkORCID,Chapman JessicaORCID,Connors Dana E.ORCID,Dash AjeetaORCID,Di Bacco AlessandraORCID,Du Ling,Facon Thierry,Flores-Montero JuanORCID,Gay FrancescaORCID,Ghobrial Irene M.,Gormley Nicole J.,Gupta Ira,Higley Howard,Hillengass JensORCID,Kanapuru Bindu,Kazandjian Dickran,Kelloff Gary J.,Kirsch Ilan R.,Kremer Brandon,Landgren OlaORCID,Lightbody Elizabeth,Lomas Oliver C.ORCID,Lonial Sagar,Mateos María-Victoria,Montes de Oca RocioORCID,Mukundan Lata,Munshi Nikhil C.,O'Donnell Elizabeth K.,Orfao Alberto,Paiva Bruno,Patel Reshma,Pugh Trevor J.ORCID,Ramasamy KarthikORCID,Ray Jill,Roshal Mikhail,Ross Jeremy A.,Sigman Caroline C.ORCID,Thoren Katie L.ORCID,Trudel Suzanne,Ulaner Gary,Valente Nancy,Weiss Brendan M.,Zamagni Elena,Kumar Shaji K.

Funder

Foundation for the National Institutes of Health

Multiple Myeloma Research Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3